Japanese Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation [J-POPS]
- To determine the efficacy of permanent brachytherapy with iodine I 125 seeds in
patients with localized prostate cancer.
- To determine the safety of this therapy in these patients.
OUTLINE: This is a multicenter study.
Patients undergo permanent brachytherapy seed implantation comprised of iodine I 125 into
the prostate. Some patients may receive combination treatment (e.g., external beam radiation
therapy (EBRT) or hormone therapy in addition to brachytherapy).
Quality of life and the International Prostate Symptom Score (IPSS) is assessed and
Primary Purpose: Treatment
PSA relapse-free survival
Hidetoshi Yamanaka, MD, PhD
Translational Research Informatics Center, Kobe, Hyogo, Japan
United States: Federal Government